New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

HealthDay News — The FDA has approved Surfaxin (lucinactant) to prevent respiratory distress syndrome (RDS) in premature infants. Premature infants born before 37 weeks’ gestation often cannot produce ...

The results show COVID shots in pregnancy can offer protection, researchers say. Unvaccinated pregnant people who contracted COVID-19 were more likely to have babies who suffered from respiratory ...

Objective: The aim of the study was to measure pulmonary mechanics in infants with respiratory distress syndrome before extubation and to correlate pulmonary function values with successful extubation ...

Steroids for women at risk of preterm birth improve lung development and reduces risk of severe respiratory distress in babies, shows new research. Currently, corticosteroids are recommended for women ...

The most likely diagnosis for this infant is bronchiolitis. This illness is the most common reason for hospitalization of an infant or preschool-age child in the United States. [1] Bronchiolitis is ...

The article as published, omitted the length of stay data and reported only the mortality data. It does have multiple regression analyses ‘correcting’ for possible differences in risk among patients ...

clinical-challenge-respiratory-distress-CA0516 A congenital condition is found in an infant with respiratory and gastrointestinal symptoms. Lily, a 6-week-old infant, presents with difficulty ...

In a recent study published in Environmental Research, researchers investigated whether surgical and N95 face masks cause respiratory distress in children. In the present study, researchers assessed ...

Nasal high-flow therapy is an alternative to nasal continuous positive airway pressure (CPAP) as a means of respiratory support for newborn infants. The efficacy of high-flow therapy in nontertiary ...